New Study Links NSTEMI to Acute Coronary Occlusion
Researchers find that 15 percent of NSTEMI patients exhibit acute coronary occlusions linked to worse clinical outcomes.
Updated on Oct. 21, 2026 in Heart Disease

A large-scale analysis of data collected from April 1, 2018, to June 30, 2023, reveals that 15 percent of patients diagnosed with NSTEMI actually have acute coronary occlusions. These patients face a significantly higher risk of adverse events compared to those without such occlusions.
Why it matters
Identifying these occlusions is critical because patients categorized as NSTEMI-ACO experience higher rates of life-threatening complications like cardiac arrest and cardiogenic shock. This study highlights the clinical necessity of distinguishing between these patient groups to improve in-hospital outcomes.
The study included 1,198,544 patients, finding an adjusted odds ratio of 2.26 for primary outcomes in NSTEMI-ACO patients compared to those without occlusions. The incidence of such occlusions reaches 24 percent when including TIMI flow grades 0 to 1.
The details
By categorizing over 1.1 million PCI procedures, researchers demonstrated that NSTEMI-ACO patients are more likely to suffer stroke, myocardial infarction, or cardiovascular mortality than those without the occlusion. While NSTEMI-ACO patients have better outcomes than STEMI patients, they remain a high-risk group requiring specialized care.
Timeline
April 1, 2018 to June 30, 2023: The data collection period for patients included in the study.
Health Landscape
The CathPCI Registry provides the standardized framework needed to track coronary intervention outcomes across U.S. hospitals. This study utilizes the registry to refine existing diagnostic categories for non-ST-elevation myocardial infarction.
Patients diagnosed with NSTEMI should discuss the specific classification of their occlusion with their cardiologist to better understand their risk profile. This distinction may influence the urgency and approach required for subsequent cardiac intervention or monitoring.
The takeaway
Clinicians must look beyond traditional NSTEMI labels to recognize that a significant subset of patients harbors hidden occlusions that demand more aggressive care. Improved recognition of these high-risk cases can lead to more tailored treatment strategies that prioritize patient safety and recovery.
Further reading
For more information on current treatment standards, visit the Heart Disease section.










